Sharps Technology (STSS) Competitors $6.69 +0.39 (+6.19%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$6.70 +0.01 (+0.13%) As of 10/8/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock STSS vs. SIBN, BFLY, BVS, ZIMV, AVNS, KIDS, CBLL, SMLR, TMCI, and DCTHShould you be buying Sharps Technology stock or one of its competitors? The main competitors of Sharps Technology include SiBone (SIBN), Butterfly Network (BFLY), Bioventus (BVS), ZimVie (ZIMV), Avanos Medical (AVNS), OrthoPediatrics (KIDS), CeriBell (CBLL), Semler Scientific (SMLR), Treace Medical Concepts (TMCI), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. Sharps Technology vs. Its Competitors SiBone Butterfly Network Bioventus ZimVie Avanos Medical OrthoPediatrics CeriBell Semler Scientific Treace Medical Concepts Delcath Systems SiBone (NASDAQ:SIBN) and Sharps Technology (NASDAQ:STSS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment. Do institutionals & insiders hold more shares of SIBN or STSS? 98.1% of SiBone shares are owned by institutional investors. Comparatively, 17.2% of Sharps Technology shares are owned by institutional investors. 4.0% of SiBone shares are owned by insiders. Comparatively, 1.2% of Sharps Technology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has higher earnings and valuation, SIBN or STSS? Sharps Technology has lower revenue, but higher earnings than SiBone. SiBone is trading at a lower price-to-earnings ratio than Sharps Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSiBone$167.18M3.92-$30.91M-$0.56-27.16Sharps Technology$222.72K799.03-$9.30M-$1.21 thousand-0.01 Does the media refer more to SIBN or STSS? In the previous week, Sharps Technology had 3 more articles in the media than SiBone. MarketBeat recorded 11 mentions for Sharps Technology and 8 mentions for SiBone. Sharps Technology's average media sentiment score of 1.00 beat SiBone's score of 0.44 indicating that Sharps Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SiBone 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sharps Technology 3 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, SIBN or STSS? SiBone has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Sharps Technology has a beta of 2.17, indicating that its share price is 117% more volatile than the S&P 500. Is SIBN or STSS more profitable? Sharps Technology has a net margin of 0.00% compared to SiBone's net margin of -12.83%. Sharps Technology's return on equity of -8.72% beat SiBone's return on equity.Company Net Margins Return on Equity Return on Assets SiBone-12.83% -14.20% -10.38% Sharps Technology N/A -8.72%-5.30% Do analysts prefer SIBN or STSS? SiBone currently has a consensus target price of $23.67, suggesting a potential upside of 55.60%. Given SiBone's stronger consensus rating and higher probable upside, equities analysts clearly believe SiBone is more favorable than Sharps Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SiBone 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Sharps Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummarySharps Technology beats SiBone on 9 of the 16 factors compared between the two stocks. Get Sharps Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for STSS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STSS vs. The Competition Export to ExcelMetricSharps TechnologyMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$167.59M$10.57B$6.10B$10.55BDividend YieldN/A1.87%5.69%4.75%P/E Ratio-0.0121.8785.4727.60Price / Sales799.0332.51582.22224.03Price / CashN/A25.4637.9261.55Price / Book0.063.4513.136.76Net Income-$9.30M$208.83M$3.30B$275.88M7 Day Performance-0.89%1.63%4.29%2.81%1 Month Performance-29.13%2.06%9.45%9.24%1 Year PerformanceN/A-5.12%86.64%35.42% Sharps Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STSSSharps Technology1.569 of 5 stars$6.69+6.2%N/AN/A$167.59M$222.72K-0.013Positive NewsAnalyst ForecastBuyback AnnouncementGap UpSIBNSiBone3.9615 of 5 stars$14.56+0.5%$23.67+62.5%+13.1%$628.13M$185.26M-26.00350Positive NewsAnalyst ForecastBFLYButterfly Network2.2548 of 5 stars$2.37-7.6%$3.00+26.8%+48.2%$597.88M$82.06M-8.48460Analyst ForecastOptions VolumeBVSBioventus3.2314 of 5 stars$6.69-1.5%$13.75+105.5%-41.7%$554.36M$564.14M-10.991,200ZIMVZimVie1.3552 of 5 stars$18.93+0.0%$17.75-6.2%+21.8%$533.87M$449.75M-27.041,770Analyst ForecastAVNSAvanos Medical2.0753 of 5 stars$11.45-1.1%N/A-49.0%$532.23M$692.50M-1.142,227Positive NewsKIDSOrthoPediatrics4.6299 of 5 stars$18.13-0.6%$34.14+88.4%-26.1%$454.47M$220.73M-10.13200Positive NewsAnalyst ForecastCBLLCeriBell2.3603 of 5 stars$12.05-4.2%$32.14+166.9%N/A$441.72M$65.44M-4.03N/ANews CoveragePositive NewsAnalyst ForecastInsider TradeSMLRSemler Scientific3.2842 of 5 stars$28.40-7.6%$74.25+161.4%+10.1%$424.30M$42.98M11.79120Analyst ForecastGap UpTMCITreace Medical Concepts2.5378 of 5 stars$6.12-2.9%$9.83+60.8%+18.9%$386.60M$209.36M-7.75250News CoverageAnalyst ForecastDCTHDelcath Systems2.638 of 5 stars$10.94+1.3%$24.50+123.9%+31.5%$383.92M$70.24M219.5060Analyst Forecast Related Companies and Tools Related Companies SiBone Competitors Butterfly Network Competitors Bioventus Competitors ZimVie Competitors Avanos Medical Competitors OrthoPediatrics Competitors CeriBell Competitors Semler Scientific Competitors Treace Medical Concepts Competitors Delcath Systems Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STSS) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sharps Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sharps Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
